|Videos|June 10, 2021
Ushering in the Golden Era of Alzheimer Drug Development?
Author(s)RJ Tesi, MD
What effect will aducanumab have on Alzheimer disease treatment?
Advertisement
RJ Tesi, MD, discusses the recent aducanumab FDA approval and the implications it will have on the treatment of Alzheimer disease.
Dr Tesi is CEO and Chief Medical Officer of
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
NDA Submission: Olanzapine Extended-Release Injectable Suspension for Treatment of Schizophrenia
2
Evenamide for Treatment-Resistant Schizophrenia: Initiation of ENIGMA-TRS 2 Phase 3 Clinical Study
3
FDA Accepts NDA for TRN-257 for Treatment of Narcolepsy and Idiopathic Hypersomnia
4
Data Fails to Show Significant Change in Cognition and Function With Oral Semaglutide for Early Alzheimer Disease
5
